SK bioscience Co.,Ltd. (KRX:302440)
South Korea
· Delayed Price · Currency is KRW 45,850
+400 (0.88%)
At close: Aug 11, 2025, 3:30 PM KST
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 3.66 trillion as of August 14, 2025. Its market cap has decreased by -12.53% in one year.
Market Cap
3.66T
Enterprise Value
3.19T
Revenue
399.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
45,850.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 3.66T, a decrease of -71.72%. That is a compound annual growth rate of -24.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 3,601.06B | -8.80% |
| Dec 30, 2024 | 3,948.70B | -28.57% |
| Dec 28, 2023 | 5,528.45B | -2.04% |
| Dec 29, 2022 | 5,643.63B | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.67T |
| Celltrion | 38.01T |
| ALTEOGEN | 23.22T |
| Yuhan | 8,309.02B |
| SK Biopharmaceuticals | 7,737.35B |
| Peptron | 7,117.34B |
| PharmaResearch | 6,950.67B |
| LigaChem Biosciences | 5,361.69B |